Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
RET expression
i
Other names:
RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5979
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
RET mutation (20)
RET M918T (12)
RET rearrangement (11)
RET C634W (9)
RET-PTC1 rearrangement (8)
RET C634R (4)
RET C634Y (2)
RET G810C (2)
RET G810D (2)
RET G810R (2)
RET G810S (2)
RET G810V (2)
RET L629P (2)
RET V804L (2)
RET V804M (2)
BRAF V600E + TERT E441del + RET N579K + EZH2 D154E + CDK4 S259L (1)
RET C618R (1)
RET C620R (1)
RET C634* (1)
RET C634F (1)
RET D631_R635delinsG (1)
RET M918T + ATM L804fs*4 + ATM S978fs*12 (1)
RET V637R (1)
RET V804* (1)
RET V804M + M918T (1)
RET V804M + RET M918T + RET G810 + RET Y806 (1)
RET Y900_S904delinsP (1)
RET wild-type (1)
RET mutation (20)
RET M918T (12)
RET rearrangement (11)
RET C634W (9)
RET-PTC1 rearrangement (8)
RET C634R (4)
RET C634Y (2)
RET G810C (2)
RET G810D (2)
RET G810R (2)
RET G810S (2)
RET G810V (2)
RET L629P (2)
RET V804L (2)
RET V804M (2)
BRAF V600E + TERT E441del + RET N579K + EZH2 D154E + CDK4 S259L (1)
RET C618R (1)
RET C620R (1)
RET C634* (1)
RET C634F (1)
RET D631_R635delinsG (1)
RET M918T + ATM L804fs*4 + ATM S978fs*12 (1)
RET V637R (1)
RET V804* (1)
RET V804M + M918T (1)
RET V804M + RET M918T + RET G810 + RET Y806 (1)
RET Y900_S904delinsP (1)
RET wild-type (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
RET expression
Acute Myelogenous Leukemia
RET expression
Acute Myelogenous Leukemia
venetoclax + ivosidenib
Sensitive: C3 – Early Trials
venetoclax + ivosidenib
Sensitive
:
C3
venetoclax + ivosidenib
Sensitive: C3 – Early Trials
venetoclax + ivosidenib
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.